Komori
Anest Iwata (6381) · InitiativeSigns of recovery alongside a full-year revenue decline

Acquisition of the Medium- and Large-Sized Screw Compressor Business and China Sales Platform through Making Shanghai 斯可絡圧縮機 a Subsidiary

First written in FY2018-Q2. 9 of 13 entries say "Advanced", first in FY2019-Q1. Latest entry: FY2026.

13entries
10years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseAdvancedFY2018-Q3 – FY2025-H12017: 12018: 320182019: 120192020: 020202021: 320212022: 120222023: 120232024: 120242025: 120252026: 12026
Same theme, other companies

5 other companies' latest entry also says "Other".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 189 companies compared. The sentences above are computed from all 189.Comparing 200 of the theme's 318 threads.
Full recordFilings, disclosures and news, newest first
  1. FY2026Signs of recovery alongside a full-year revenue declineAnnual report

    「For compressor products, domestic sales recovered as the Chinese market showed signs of bottoming out, and sales expanded as business conditions in export markets recovered. However, the decline through the third quarter could not be offset in the fourth quarter, and sales decreased year on year.」

    In the Chinese compressor business, including 上海斯可絡圧縮機有限公司, domestic and export sales showed signs of recovery, but full-year sales decreased.
  2. FY2026-H1WorsenedAnnual report

    「Sales of compressor products declined as the contraction in domestic demand in China and the decline in export sales of medium-sized compressors to the European market continued.」

    For the compressor business and sales base established in China, declining domestic demand and continued decreases in exports of medium-sized compressors to Europe remain issues.
  3. FY2025-H1AdvancedAnnual report

    「For compressor products, export sales from the country remained firm while domestic demand continued to contract.」

    While domestic demand in China continued to shrink, export sales by Chinese subsidiaries and other entities remained firm.
  4. FY2023-Q3AdvancedAnnual report

    「Compressor products have turned toward recovery as lockdown restrictions were lifted. Sales, including exports by 上海斯可絡圧縮機有限公司, and sales of compressors for fuel-cell manufacturing have continued to perform well.」

    For 上海斯可絡圧縮機有限公司, domestic sales in China and export sales continued to perform well, while sales of compressors for fuel-cell manufacturing also contributed to growth.
  5. FY2023-Q1AdvancedAnnual report

    「Sales of compressor products in China remained strong.」

    Sales in China continued to perform strongly for the compressor sales platform in China, including Shanghai Sikeluo Compressor Co., Ltd.
  6. FY2022-Q1AdvancedAnnual report

    「In compressor products, sales by Shanghai Sikeluo Compressor Co., Ltd. expanded in China as well as to Europe, Asia and North America, resulting in higher sales.」

    For Shanghai Sikeluo Compressor Co., Ltd., sales expanded not only in China but also to Europe, Asia and North America, resulting in higher sales.
  7. FY2021AdvancedAnnual report

    「Shanghai Sikeluo Compressor Co., Ltd. Net sales 3,866 Ordinary income 292 Net income 260」

    Shanghai Sikeluo Compressor Co., Ltd. became a major subsidiary accounting for more than 10% of consolidated net sales, recording net sales of ¥3,866 million and ordinary income of ¥292 million.
  8. FY2021-Q3AdvancedAnnual report

    「In China, domestic sales expanded due to increased demand for large oil-injected screw compressors and compressors for vehicle mounting. Exports by the local subsidiary Shanghai Sikeluo Compressor Co., Ltd. also remained strong, resulting in higher sales.」

    For Shanghai Sikeluo Compressor Co., Ltd., exports remained strong in addition to domestic sales of large compressors and compressors for vehicle mounting in China.
  9. FY2019AdvancedAnnual report

    「The strong performance of Shanghai Sikeluo Compressor Co., Ltd., a Chinese screw compressor manufacturing and sales company that became a consolidated subsidiary at the end of the previous consolidated fiscal year, and ANEST IWATA SPARMAX Co., Ltd., a Taiwanese subsidiary manufacturing and selling airbrushes and small compressors for medical applications that became a consolidated subsidiary during the current consolidated fiscal year, contributed to the growth of our Group.」

    Shanghai Sikeluo's sales platform in China and SPARMAX's small compressors and other products contributed to growth in the current fiscal year.
  10. FY2019-Q2AdvancedAnnual report

    「In addition, the performance of a Chinese compressor manufacturing and sales company that became subject to consolidation from the current fiscal year made a significant contribution.」

    The Chinese compressor manufacturing and sales company that became a subsidiary in the previous fiscal year made a significant contribution to the current year's performance.
  11. FY2019-Q1AdvancedAnnual report

    「In addition, sales by Shanghai Sikeluo Compressor Co., Ltd., which became a consolidated subsidiary in the previous fiscal year, have also grown, mainly in China.」

    Sales by Shanghai Sikeluo Compressor Co., Ltd., which became a subsidiary in the previous fiscal year, grew, mainly in China.
  12. FY2018-Q3AchievedAnnual report

    「(3) Date of business combination 18 December 2017 (date of acquisition of equity interests) 31 December 2017 (deemed acquisition date) (6) Voting rights ratio acquired 51%」

    The acquisition of an equity interest in Shanghai Sikeluo Compressor Co., Ltd. was completed on 18 December 2017. The company and its subsidiaries became consolidated subsidiaries with a 51% voting rights ratio. The medium- and large-sized screw compressor business and sales platform in China were acquired.
  13. FY2018-Q2First statedAnnual report

    「(2) Main reasons for the business combination Acquisition of the medium- and large-sized screw compressor business and a strong domestic sales platform in China (3) Timing of acquisition of equity interests January 2019 (scheduled) (6) Voting rights ratio to be acquired 51%」

    The objectives for Shanghai Sikeluo Compressor Co., Ltd. were specified as acquiring an equity interest, scheduled for January 2019, of 51% of voting rights, together with the medium- and large-sized screw compressor business and a domestic sales platform in China.
Moved together

"Expansion of Vacuum Equipment into the General Industrial Market" moved the same way as this thread, in the same document, in 10 of its 13 moves.

1099866★123456
  1. ★This thread
  2. 1Expansion of Vacuum Equipment into the General Industrial Market10×
  3. 2Addressing Regional Challenges and Providing Added Value Through Specialization9×
  4. 3High equity ratio9×
  5. 4Securing and Developing Global Talent and Exchanges among Overseas Operations8×
  6. 5Stagnant Demand in China and Southeast Asia and Reduced Production at the Chinese Manufacturing Subsidiary6×
  7. 6Impact on performance from yen appreciation and foreign-exchange volatility6×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
No upcoming earnings preview for Anest Iwata yet.
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Acquisition of the Medium- and Large-Sized Screw Compressor Business and China Sales Platform through Making Shanghai 斯可絡圧縮機 a Subsidiary | ANEST IWATA Corporation (6381) | Komori